TORTI, Carlo
 Distribuzione geografica
Continente #
NA - Nord America 5.674
AS - Asia 4.068
EU - Europa 2.047
SA - Sud America 1.097
AF - Africa 96
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 11
Totale 13.008
Nazione #
US - Stati Uniti d'America 5.444
SG - Singapore 1.896
IT - Italia 902
CN - Cina 876
BR - Brasile 858
IN - India 509
VN - Vietnam 457
GB - Regno Unito 287
SE - Svezia 258
DE - Germania 213
CA - Canada 163
AR - Argentina 85
FI - Finlandia 78
HK - Hong Kong 68
EC - Ecuador 57
NL - Olanda 53
ID - Indonesia 49
MX - Messico 49
RU - Federazione Russa 38
IQ - Iraq 36
BD - Bangladesh 34
ZA - Sudafrica 29
FR - Francia 28
CZ - Repubblica Ceca 27
ES - Italia 27
CO - Colombia 26
PL - Polonia 26
JP - Giappone 25
UA - Ucraina 25
TR - Turchia 24
RO - Romania 21
VE - Venezuela 21
PY - Paraguay 19
CL - Cile 18
EG - Egitto 17
SA - Arabia Saudita 17
TN - Tunisia 11
UZ - Uzbekistan 11
KE - Kenya 10
A2 - ???statistics.table.value.countryCode.A2??? 9
AE - Emirati Arabi Uniti 9
AT - Austria 8
IL - Israele 8
PK - Pakistan 8
PE - Perù 7
AU - Australia 6
DO - Repubblica Dominicana 6
ET - Etiopia 6
IE - Irlanda 6
LT - Lituania 6
AL - Albania 5
AM - Armenia 5
BG - Bulgaria 5
EU - Europa 5
GR - Grecia 5
MA - Marocco 5
NG - Nigeria 5
AZ - Azerbaigian 4
CH - Svizzera 4
IR - Iran 4
KR - Corea 4
NO - Norvegia 4
NP - Nepal 4
UY - Uruguay 4
DZ - Algeria 3
EE - Estonia 3
GT - Guatemala 3
KZ - Kazakistan 3
LV - Lettonia 3
MY - Malesia 3
PH - Filippine 3
TT - Trinidad e Tobago 3
BE - Belgio 2
BO - Bolivia 2
DK - Danimarca 2
GH - Ghana 2
HN - Honduras 2
HR - Croazia 2
JM - Giamaica 2
JO - Giordania 2
LB - Libano 2
MD - Moldavia 2
RS - Serbia 2
TO - Tonga 2
TZ - Tanzania 2
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
DM - Dominica 1
GA - Gabon 1
KG - Kirghizistan 1
KI - Kiribati 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MW - Malawi 1
MZ - Mozambico 1
NZ - Nuova Zelanda 1
Totale 12.999
Città #
Chandler 900
Singapore 589
Santa Clara 425
Bengaluru 399
Hefei 397
Dallas 369
Milan 341
Princeton 334
Lawrence 332
Ashburn 228
Chicago 222
London 222
Wilmington 216
Ho Chi Minh City 182
Munich 165
Ottawa 124
Des Moines 98
Hanoi 94
Beijing 87
São Paulo 74
Boardman 72
Hong Kong 64
Turku 64
Los Angeles 56
Rome 47
New York 37
Pune 36
Brooklyn 34
San Francisco 33
Norwalk 32
Guangzhou 31
Shanghai 31
Redwood City 29
Catanzaro 28
Council Bluffs 28
Olomouc 27
Rio de Janeiro 26
Haiphong 24
Palermo 24
The Dalles 23
Guayaquil 22
Warsaw 22
Woodbridge 22
Tokyo 21
Chennai 20
Crotone 20
Houston 20
San Nicola Manfredi 20
Wuhan 20
Belo Horizonte 19
Thái Bình 18
Atlanta 17
Boston 17
Da Nang 17
Fairfield 17
Naples 16
Salvador 16
Stockholm 16
Baghdad 15
Quito 15
Phoenix 14
Shenzhen 14
Brasília 13
Cosenza 13
Helsinki 13
Jakarta 13
Montreal 13
Porto Alegre 13
Charlotte 12
Hanover 12
Piracicaba 12
Rende 12
Rui'an 12
Bogotá 11
Redmond 11
Seattle 11
Amsterdam 10
Curitiba 10
Johannesburg 10
Mexico City 10
Settingiano 10
Tashkent 10
Ankara 9
Asunción 9
Bari 9
Biên Hòa 9
Caracas 9
Padova 9
Taranto 9
Ann Arbor 8
Buenos Aires 8
Caxias do Sul 8
Columbus 8
Denver 8
Goiânia 8
Guarulhos 8
Nairobi 8
Phủ Lý 8
Bauru 7
Campinas 7
Totale 7.322
Nome #
Severe hepatotoxicity during combination antiretroviral treatment: Incidence, liver histology, and outcome 110
Analysis of the persistence time of the SARS-CoV-2 virus in the cadaver and the risk of passing infection to autopsy staff 94
The Role of Gut Microbiota in the Clinical Outcome of Septic Patients: State of the Art and Future Perspectives 81
A case report of pneumomediastinum in a COVID-19 patient treated with high-flow nasal cannula and review of the literature: Is this a “spontaneous” complication? 74
Ochrobactrum anthropi 72
Varicella zoster immunity loss in multiple sclerosis patient treated with ocrelizumab 67
Multidisciplinary approach to a septic COVID-19 patient undergoing veno-venous extracorporeal membrane oxygenation and receiving thoracic surgery 64
A CASE REPORT OF SCHISTOSOMA HAEMATOBIUM INFECTION IN A PREGNANT MIGRANT RAISES CONCERNS ABOUT LACK OF SCREENING POLICIES. 64
Influence of genotype 3 hepatitis C coinfection on liver enzyme elevation in HIV-1-positive patients after commencement of a new highly active antiretroviral regimen: results from the EPOKA-MASTER Cohort. 62
A Rare Complication of Ascariasis: A Case of Acute Interstitial Nephritis 61
Clinical characteristics and predictors of mortality associated with COVID-19 in elderly patients from a long-term care facility 61
Pursuing Later Treatment Options II (PLATO II) Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord. Higher rates of triple-class virological failure in perinatally HIV infected teenagers compared with heterosexually infected young adults in Europe 60
The spike-specific TCRβ repertoire shows distinct features in unvaccinated or vaccinated patients with SARS-CoV-2 infection 58
Persistence of SARS-CoV-2 infection and viral intra- and inter-host evolution in COVID-19 hospitalized patients 58
Apparent inefficacy of hydroxychloroquine combined with azithromycin on SARS-CoV-2 clearance in an incident cohort of geriatric patients with COVID-19 58
Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study 56
Molecular recognition studies of dasabuvir, tegobuvir, and setrobuvir against natural Hepatitis C Virus NS5B polymerase variants. 56
EFFICACY OF CEFIDEROCOL- VERSUS COLISTIN-CONTAINING REGIMEN FOR TREATMENT OF BACTEREMIC VENTILATOR-ASSOCIATED PNEUMONIA CAUSED BY CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII IN COVID-19 PATIENTS 55
RegaDB: community-driven data management and analysis for infectious diseases 55
Knowledge of HIV infection and transmission: a knowledge, attitudes, beliefs and practices (KABP) survey among a sample of students at the "Magna Graecia", University of Catanzaro 55
Evolving phenotypes of non-hospitalized patients that indicate long COVID 55
Prevalence of Antibiotic Resistance Over Time in a Third-Level University Hospital 54
Low compliance with hepatocellular carcinoma screening guidelines in hepatitis B/C virus co-infected HIV-patients with cirrhosis. 54
Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study 53
Successful treatment with cefiderocol for compassionate use in a critically ill patient with XDR Acinetobacter baumannii and KPC-producing Klebsiella pneumoniae: a case report. 53
A randomized controlled trial to evaluate antiretroviral salvage therapy guided by rules-based or phenotype-driven HIV-1 genotypic drug-resistance interpretation with or without concentration-controlled intervention: The resistance and dosage adapted regimens (RADAR) study 52
Challenging clinical cases in HCV infection 52
Effectiveness of adjunctive gabapentin in resistant bipolar disorder: Is it due to anxious-alcohol abuse comorbidity? 52
Protein and vitamin B6 intake are associated with liver steatosis assessed by transient elastography, especially in obese individuals 52
Use of colistin in adult patients: a cross-sectional study 52
Direct antimicrobial susceptibility testing (AST) from positive blood cultures using Microscan system for early detection of bacterial resistance phenotypes 52
SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections 51
Adiponectin serum level in chronic hepatitis C infection and therapeutic profile 51
Clinical outcomes of patients treated with intravenous zanamivir for severe influenza A(H1N1)pdm09 infection: a case report series. 51
HCV antibody prevalence and genotype evolution in a teaching hospital, Calabria Region, southern Italy over a decade (2008-2018) 51
y CD4 Cell Count and the Risk of AIDS or Death in HIV-Infected Adults on Combination Antiretroviral Therapy with a Suppressed Viral Load: A Longitudinal Cohort Study from COHERE 50
Therapy with RAS inhibitors during the COVID-19 pandemic 50
A king in the CASTLE? Optimum initial HIV protease inhibitor. 49
Calendar Time Trends in the Incidence and Prevalence of Triple-Class Virologic Failure in Antiretroviral Drug-Experienced People With HIV in Europe 49
Analysis of dominant viral populations isolated from two pediatric patients infected by HCV genotype 4. 49
Combined lymphocyte/monocyte count, D-dimer and iron status predict COVID-19 course and outcome in a long-term care facility 49
Adaptive optics optical coherence tomography at 120,000 depth scans/s for non-invasive cellular phenotyping of the living human retina 48
A new basal subfamily of mariner elements in Ceratitis rosa and other tephritid flies 48
A randomized, controlled trial of triple antiviral therapy as initial treatment of chronic hepatitis C in HIV-infected patients 48
A case report of nasopharyngeal carcinoma in a Caucasian Italian man 48
Depression of lymphocyte activity during cutaneous leishmaniasis: a case report. 48
Role of the T2Dx magnetic resonance assay in patients with suspected bloodstream infection: a single-centre real-world experience 48
Allozyme divergence and phylogenetic relationships among species of tephritid flies 47
Adherence and plasma drug concentrations are predictors of confirmed virologic response after 24-week salvage highly active antiretroviral therapy 47
A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapy 47
Mortality in KPC-producing Klebsiella pneumoniae bloodstream infections: a changing landscape 46
Response to combination antiretroviral therapy: variation by age - The Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study group 46
2018 update to the HIV-TRePS system: the development of new computational models to predict HIV treatment outcomes, with or without a genotype, with enhanced usability for low-income settings. 46
Predictivity of frontal QRS-T angle for death in COVID-19 patients may differ by age 46
Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid-19 Hospitalized Patients through Hierarchical Clustering 45
Discussion on critical points for a tailored therapy to cure hepatitis C virus infection 45
Virologic and resistance markers in HIV infection: rationale, state of ART and perspective in clinical practice 45
HIV-1 pharmacoresistance: clinical and therapeutic implications 45
A Randomized, Pilot Trial to Evaluate Glomerular Filtration Rate by Creatinine or Cystatin C in Naive HIV-Infected Patients After Tenofovir/Emtricitabine in Combination With Atazanavir/Ritonavir or Efavirenz 45
Is hand-grip another culprit for the risk of fractures in HIV-positive patients? 45
Pharmacokinetics of efavirenz (EFV) alone and in combination therapy with nelfinavir (NFV) in HIV-1 infected patients 45
Dynamics of Viral Infection and Evolution of SARS-CoV-2 Variants in the Calabria Area of Southern Italy 45
Factors associated with short-term changes in HIV viral load and CD4(+) cell count in antiretroviral-naive individuals 44
Increasing clinical virulence in two decades of the Italian HIV epidemic 44
Back to the origin of HCV 2c subtype and spreading to the Calabria region (Southern Italy) over the last two centuries: A phylogenetic study 44
Characteristics, management, and outcomes of elderly patients with diabetes in a covid-19 unit: Lessons learned from a pilot study 44
Acute respiratory distress syndrome after SARS-CoV-2 infection on young adult population: International observational federated study based on electronic health records through the 4CE consortium 43
Genomic organization and characterization of the white locus of the Mediterranean fruitfly, Ceratitis capitata 43
Analysis of HIV-1 mutation patterns in patients failing antiretroviral therapy 43
"Solving the puzzle" of current HAART: What key strategic trials are needed? 43
Evaluation of Liver Fibrosis: Concordance Analysis between Noninvasive Scores (APRI and FIB-4) Evolution and Predictors in a Cohort of HIV-Infected Patients without Hepatitis C and B Infection 43
The evolving burden of HIV infection compared with other chronic diseases in northern Italy 43
Listeria infection after treatment with alemtuzumab: A case report and literature review. would antibiotic prophylaxis be considered? 43
Is neutrophil gelatinase associated lipocalin useful in hepatitis C virus infection? 43
Seroprevalence and age-related susceptibility of TORCH infections in childbearing age women: a 5-year cross-sectional retrospective study and a literature review 42
Risk of Chronic Kidney Disease among Patients Developing Mild Renal Impairment during Tenofovir-Containing Antiretroviral Treatment 42
HIV/HTLV co-infection: frequency and epidemiological characteristics among patients admitted to an Italian hospital 42
Drug resistance mutations and newly recognized treatment-related substitutions in the HIV-1 protease gene: Prevalence and associations with drug exposure and real or virtual phenotypic resistance to protease inhibitors in two clinical cohorts of antiretroviral experienced patients 42
Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen 42
Virological Mechanisms in the Coinfection between HIV and HCV 42
Evidence of Low Prevalence of Cystic Echinococcosis in the Catanzaro Province, Calabria Region, Italy. 42
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes 41
R211K and L214F ho not invariably confer high level phenotypic resistance to thymidine analogs in zidovndine-naive patients with M184V 41
Genetic aspects of the worldwide colonization process of Ceratitis capitata 41
Exploratory analysis for the evaluation of lopinavir/ritonavir-versus efavirenz-based HAART regimens in antiretroviral-naive HIV-positive patients: results from the Italian MASTER Cohort 41
Head to head comparison of widely used HIV-1 drug resistance algorithms: Retrogram ® and VGI-Trugene HIV-1 ® 41
Histopathological findings in a COVID-19 patient affected by ischemic gangrenous cholecystitis 41
Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study 41
Phylogenetic and Molecular Analyses of More Prevalent HCV1b Subtype in the Calabria Region, Southern Italy 41
Late-onset myocardial infarction and autoimmune haemolytic anaemia in a COVID-19 patient without respiratory symptoms, concomitant with a paradoxical increase in inflammatory markers: a case report 41
Role of IgG and IgM and proinflammatory aspecific markers in the diagnosis and prognosis of COVID-19 patients stratified by number of positive SARS-CoV-2 genes 41
Intron size polymorphism of the Adh(1) gene parallels the worldwide colonization history of the Mediterranean fruit fly, Ceratitis capitata 40
The Disagreement Among Methods to Evaluate Glomerular Filtration Rate in HIV-Infected Patients Naive to Antiretroviral Therapy. 40
A population-based database to study malignancies in HIV-infected patients in the Local Health Unit of Brescia (Northern Italy), period 1999-2009 40
Unboosted Atazanavir for Treatment of HIV Infection Rationale and Recommendations for Use 40
Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia 40
Structural equation modelling of viral tropism reveals its impact on achieving viral suppression within 6 months in treatment-naive HIV-1-infected patients after combination antiretroviral therapy 40
Selection of antiretroviral therapy guided by genotypic or phenotypic resistance testing - An open-label, randomized, multicenter study (PhenGen) 40
Is the Pendulum of Antimicrobial Drug Resistance Swinging Back after COVID-19? 39
Are we doing enough for controlling tuberculosis and multi-drug resistance in an epicenter of the current migration emergency (Calabria Region, Southern Italy)? 39
Totale 4.957
Categoria #
all - tutte 159.974
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 159.974


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021158 0 0 0 0 17 31 16 32 34 16 3 9
2021/2022880 9 3 12 236 30 17 41 216 58 104 146 8
2022/20232.570 684 110 20 276 286 244 14 160 402 169 167 38
2023/20241.134 237 147 80 77 69 290 36 24 26 25 60 63
2024/20253.722 543 273 136 136 236 460 67 142 458 232 334 705
2025/20264.342 398 1.063 752 1.407 722 0 0 0 0 0 0 0
Totale 13.257